United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition).

[1]  W. Roush.  Hunting for Animal Alternatives , 1996, Science.

[2]  R. Maxwell,et al.  Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy. , 1996, The British journal of cancer. Supplement.

[3]  M R Grever,et al.  In vivo cultivation of tumor cells in hollow fibers. , 1995, Life sciences.

[4]  P. Flecknell.  Refinement of animal use-assessment and alleviation of pain and distress , 1994, Laboratory animals.

[5]  M. Festing,et al.  Reduction of animal use: experimental design and quality of experiments , 1994, Laboratory animals.

[6]  M Balls,et al.  Replacement of animal procedures: alternatives in research, education and testing , 1994, Laboratory animals.

[7]  D. M. Ryan,et al.  Guidelines for the welfare of animals in rodent protection tests: A Report from the Rodent Protection Test Working Party , 1994, Laboratory animals.

[8]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[9]  E. Boven.  The Nude Mouse in Oncology Research , 1991 .

[10]  M. Deutsch,et al.  Time of death of CNS tumor-bearing rats can be reliably predicted by body weight-loss patterns. , 1991, Laboratory animal science.

[11]  J. Wallace,et al.  The assessment and control of the severity of scientific procedures on laboratory animals , 1990, Laboratory animals.

[12]  W. Morgan.  Guidelines for the recognition and assessment of pain in animals. Prepared by a working party of the Association of Veterinary Teachers and Research Workers. , 1990, The Veterinary record.

[13]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.

[14]  A. A. Tuffery,et al.  Laboratory Animals: An Introduction for New Experimenters , 1987 .

[15]  J. Piatigorsky,et al.  Oncogenesis of the lens in transgenic mice. , 1987, Science.

[16]  R. A. Brennan,et al.  Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. , 1987, Journal of the National Cancer Institute.

[17]  P. Houghton,et al.  Role of murine tumor models in cancer treatment research. , 1986, Cancer research.

[18]  J. Brown,et al.  The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop. , 1985 .

[19]  P. H. Griffiths,et al.  Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment , 1985, Veterinary Record.

[20]  P. Hermanek,et al.  The adenoma-carcinoma sequence in AMMN-induced colonic tumors of the rat. , 1984, Pathology, research and practice.

[21]  D. Schmähl,et al.  Endoscopic diagnosis of chemically induced autochthonous colonic tumors in rats. , 1981, Hepato-gastroenterology.

[22]  M. Fowler.  Restraint and handling of wild and domestic animals , 1980 .

[23]  J. Gray,et al.  A new mouse tumor model system (RIF-1) for comparison of end-point studies. , 1980, Journal of the National Cancer Institute.

[24]  I. Fidler,et al.  Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. , 1978, Cancer research.

[25]  A. Goldin,et al.  Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX. , 1971, Cancer chemotherapy reports. Part 2.

[26]  Gerald B. Folland,et al.  Other References , 1965, Comparative Education Review.

[27]  W. Russell,et al.  The Principles of Humane Experimental Technique , 1960 .

[28]  D. Newell,et al.  Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development Office. , 1995, European journal of cancer.

[29]  G. Adams,et al.  The response of spontaneous and transplantable murine tumors to vasoactive agents measured by 31P magnetic resonance spectroscopy. , 1992, International journal of radiation oncology, biology, physics.

[30]  T. Poole.  UFAW Handbook on the Care and Management of Laboratory Animals , 1987 .

[31]  Quantitation of tumour response: a critical appraisal. Proceedings of the 9th L. H. Gray Conference held at St Catharine's College, Cambridge 11-14 September 1979. , 1980, The British journal of cancer. Supplement.

[32]  A. Goldin,et al.  Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X. , 1972, Cancer chemotherapy reports. Part 2.

[33]  J. Heavner.  Methods of animal experimentation , 1965 .

[34]  G. Lapage,et al.  Laboratory Animals , 1958, Nature.